MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1621 to 1640 of 166,322 approvalsPage 82 of 8317

Pregabalin Oral Solution

Approval Number: 国药准字H20253240
Registration: Jan 24, 2025
温岭市创新生物医药科技股份有限公司

Cyclopentolate Hydrochloride Eye Drops

Approval Number: 国药准字H20253278
Registration: Jan 24, 2025
山东绅联药业股份有限公司

Ixazomib Citrate Capsules

Approval Number: 国药准字H20253308
Registration: Jan 24, 2025
山东齐鲁制药有限公司

Potassium Chloride Oral Solution

Approval Number: 国药准字H20253291
Registration: Jan 24, 2025
哈尔滨誉衡制药有限公司

Ciclosporin Soft Capsules

Approval Number: 国药准字H20253226
Registration: Jan 24, 2025
山东齐鲁制药有限公司

Gemcitabine Hydrochloride for Injection

Approval Number: 国药准字H20253258
Registration: Jan 24, 2025
四川百利药业有限责任公司

Trimebutine Maleate Tablets

Approval Number: 国药准字H20253286
Registration: Jan 24, 2025
山西振东安欣生物制药有限公司

Dexmedetomidine Hydrochloride Injection

Approval Number: 国药准字H20253293
Registration: Jan 24, 2025
江西赣南海欣药业股份有限公司

Cefdinir Granules

Approval Number: 国药准字H20253255
Registration: Jan 24, 2025
广州江正医药科技有限公司

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number: 国药准字H20253231
Registration: Jan 24, 2025
江苏联环药业股份有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20253315
Registration: Jan 24, 2025
江苏德源药业股份有限公司

Amorolfine Hydrochloride Liniment

Approval Number: 国药准字H20253230
Registration: Jan 24, 2025
武汉诺安药业有限公司

Desvenlafaxine Succinate Sustained-release Tablets

Approval Number: 国药准字H20253249
Registration: Jan 24, 2025
宜昌人福药业有限责任公司

Aripiprazole Orally Disintegrating Tablets

Approval Number: 国药准字H20253237
Registration: Jan 24, 2025
北京星昊医药股份有限公司

Olmesartan Medoxomil Tablets

Approval Number: 国药准字H20253312
Registration: Jan 24, 2025
浙江华海药业股份有限公司

Cetuximab N01 Injection

Approval Number: 国药准字S20250006
Registration: Jan 24, 2025
四川科伦博泰生物医药股份有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20253304
Registration: Jan 24, 2025
河北智恒医药科技股份有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20253316
Registration: Jan 24, 2025
江苏德源药业股份有限公司

Linagliptin Tablets

Approval Number: 国药准字H20253271
Registration: Jan 24, 2025
山东鲁抗医药集团赛特有限责任公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.